SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply

JAMA. 2022 Jul 26;328(4):395-396. doi: 10.1001/jama.2022.9262.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • COVID-19* / epidemiology
  • COVID-19* / virology
  • Humans
  • Ontario / epidemiology
  • Patient Acuity
  • SARS-CoV-2*

Substances

  • Angiotensin-Converting Enzyme 2

Supplementary concepts

  • SARS-CoV-2 variants